23andMe is a consumer genetics and research company dedicated to providing individuals with access to their genetic information and insights. Founded in 2006, the company’s mission is centered around helping people understand and benefit from the human genome in ways that promote better health and personal well-being. 23andMe has been at the forefront of genetic research, having established the world's largest crowdsourced genetic research platform, with a significant majority of customers opting to participate. The company uniquely holds multiple FDA authorizations for genetic health risk reports, enhancing the value of personal genetic data. Through its Therapeutics division, 23andMe is also engaged in drug discovery programs aimed at addressing various health conditions by harnessing genetic insights. Driven by a commitment to innovation and inclusivity, the company fosters a collaborative work environment that encourages the pursuit of meaningful advancements in healthcare.